Please login to the form below

Not currently logged in
Email:
Password:

Accelerated Access Collaborative

This page shows the latest Accelerated Access Collaborative news and features for those working in and with pharma, biotech and healthcare.

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

be keen to see the arrival of Roche’s rival entrectinib, to allow greater leverage in market access negotiations. ... We welcome NHS England, government and other partners working together as part of the Accelerated Access Collaborative to address some

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • How is the NHS Long-term Plan being put into action?

    Among the changes is the right for all patients to access online or video consultations within the next few years. ... the Government recently announced changes to the Accelerated Access Collaborative (AAC), to ensure that the most promising medicines,

  • Spotlight on innovation at life sciences forum

    We will also hear from the Accelerated Access Collaborative (AAC), which was set up in 2018 to reduce the amount of time it takes for patients to benefit from ground-breaking ... Accelerated Access Collaborative(AAC). Since its recent inception, the AAC

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics